Mersana Therapeutics, Inc. Analytics - Traffic, Statistics and Competitor Tracking


Mersana Therapeutics, Inc. Website Screenshot

http://www.mersana.com

Mersana Therapeutics, Inc. Company Intro

Technology Mersana has developed highly differentiated and innovative antibody-drug conjugate (ADC) platforms, with both cytotoxic and immunostimulatory payloads, that allow for customization and optimization of ADCs for a given target and indication.  As a result, we are designing ADCs to overcome the limitations of first-generation platforms by delivering therapeutics with greater efficacy and tolerability to […]

Industry

Healthcare

Mersana Therapeutics, Inc. Headquaters

840 Memorial Drive
Cambridge,02139
United States


Mersana Therapeutics, Inc. Share price

22 Jan 2021 02:08 GMT

$21.18

-0.04 (-0.19 %)


Mersana Therapeutics, Inc. Market cap

$1.373 B


WMC RANKING

2021

Mersana Therapeutics, Inc. # 254

Biotechnology

Latest Mersana Therapeutics, Inc. News

News 12 Jan 2021

Global Antibody Drug Conjugate Market by Market Share, Vendors, Growth Rate, Analysis, Product Type, Revenue| Bayer AG, Concortis Biotherapeutics, F. Hoffman-La Roche Ltd., Immunomedics

... Type, Revenue| Bayer AG, Concortis Biotherapeutics, F. Hoffman-La Roche Ltd., ... Genentech, Heidelberg Pharma, Immunomedics, Mersana Therapeutics, ...

News 12 Jan 2021

Shares of Mersana Therapeutics, Inc. (NASDAQ:MRSN) lost ...

Mersana Therapeutics, Inc. (NASDAQ:MRSN) has a beta value of 2.51 and has seen 1,219,613 shares traded in the last trading session. The company, currently ...

News 12 Jan 2021

Global Antibody Drug Conjugate Market by Market Share, Vendors, Growth Rate, Analysis, Product Type, Revenue| Bayer AG, Concortis Biotherapeutics, F. Hoffman-La Roche Ltd., Immunomedics

... Type, Revenue| Bayer AG, Concortis Biotherapeutics, F. Hoffman-La Roche Ltd., ... Genentech, Heidelberg Pharma, Immunomedics, Mersana Therapeutics, ...


WMC Market Score


WMC Market to Revenue Score


Mersana Therapeutics, Inc. Market Financials


Revenue, Expenses, Profit


Company Currency Revenue Expense Profit Market Cap WMC Sector Score
Mersana Therapeutics, Inc. USD $859 $76,808 $-75,449 $14,540B 254
Regeneron Pharmaceuticals, Inc. USD $9,243,500 $5,152,600 $3,156,000 $578,630B 1
Alexion Pharmaceuticals, Inc. USD $5,862,400 $2,588,400 $956,600 $345,010B 2
Vertex Pharmaceuticals Incorporated USD $5,991,128 $2,596,854 $2,690,691 $615,510B 3
ALK-Abello A/S USD $3,383,000 $1,831,000 $43,000 $276,870B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total Mersana Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors



Mersana Therapeutics, Inc. Post vs Top 4 Industry Competitors




Mersana Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors



Mersana Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors



Mersana Therapeutics, Inc. WMC Market Score Calculations


Details Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Mersana Therapeutics, Inc. 0.01 1.69 4.60 0 0 0 3.23
Regeneron Pharmaceuticals, Inc. 100 66.01 28.87 100 0 0 100
Alexion Pharmaceuticals, Inc. 63.42 16.23 100 60 0 0 90.49
Vertex Pharmaceuticals Incorporated 64.81 100 8.79 86 0 0 99.87
ALK-Abello A/S 36.60 0 0 0 0 0 0

Book a demo

Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.

* required fields

You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb
Industries